Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Blackrock Technology and Private Equity Term Tru (BTX)

Blackrock Technology and Private Equity Term Tru (BTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Blackrock Technology and Private Equity Term Tru 10355 Science Center Drive SUITE 150 San Diego CA 92121 USA

www.brooklynitx.com P: 212-582-1199

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.

Key Statistics

Overview:

Market Capitalization, $K 12,059
Enterprise Value, $K -4,931
Shares Outstanding, K 58,826
Annual Sales, $ 40,691 K
Annual Net Income, $ -122,310 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,398 K
60-Month Beta 4.61
% of Insider Shareholders 20.50%
% of Institutional Shareholders 26.00%
Float, K 46,767
% Float 79.50%
Short Volume Ratio 0.28

Growth:

1-Year Return -16.48%
3-Year Return -5.34%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 60.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 07/01/22
Next Earnings Date 11/08/22
Earnings Per Share ttm -0.33
EPS Growth vs. Prev Qtr -6.25%
EPS Growth vs. Prev Year -0.83%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 11/14/25
Dividend Payable Date 11/28/25
Dividend Payout Ratio 0.00%

BTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -151.51%
Return-on-Assets % -80.34%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 45.63
Price/Cash Flow N/A
Price/Book 0.80
Book Value/Share 0.00
Interest Coverage 0.00

BTX Dividends

Date Value
11/14/25 $0.0520
10/15/25 $0.0520
09/15/25 $0.0780
08/15/25 $0.0790
06/13/25 $0.0810
05/15/25 $0.0820
04/15/25 $0.0840
03/14/25 $0.0860
02/14/25 $0.0870
01/15/25 $0.0870
12/16/24 $0.0870
11/15/24 $0.0860
10/15/24 $0.0860
09/16/24 $0.0870
08/15/24 $0.0880
07/15/24 $0.0880
06/14/24 $0.0890
05/14/24 $0.0440
04/12/24 $0.0440
03/14/24 $0.0440
02/14/24 $0.0450
01/11/24 $0.0450
12/14/23 $0.0450
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar